Top News

Review of Gilead Lung Cancer Study - Update on Phase 3 EVOKE-01 Study of Trodelvy® (sacituzumab govitecan-hziy; SG) vs. docetaxel in patients with metastatic or advanced NSCLC

primary article image

PermaLink

YouTube

Related: Investor's Business Daily

Gilead Sciences' cancer drug Trodelvy® did not improve lung caner patients' survival in a phase 3 clinical trial. Stock share price plummeted

primary article image

PermaLink

gilead

Related: CNBC

A quick rant on healthcare company Humana

primary article image

PermaLink

YouTube


Carnage at Humana - company stock plunges as earning hit due to medical costs surge

primary article image

PermaLink

CNBC

Related: YouTube, MarketWatch

Review of Pharma Company AbbVie: Part 2

primary article image

PermaLink

YouTube


Review of Pharma Company AbbVie: Part 1

primary article image

PermaLink

YouTube


Chinese gene-editing researcher Dr He Jianku, who reportedly created two gene-edited babies, starts lab in Beijing for gene therapy research, after serving 3-year jail sentence

primary article image

PermaLink

Staff Writer

Pandaily

Related: South China Morning Post, MIT Technology Review, Science, YouTube

China reports 3 cases of Covid deaths, the first time since May lockdown. With rising cases and outbreaks, the country may again tighten harsh Covid restrictions that were just eased. Markets fear further economic impact

primary article image

PermaLink

Phoebe Zhang

South China Morning Post

Related: CNN, @ScottGottliebMD, BBC, CNBC, China Daily

Merck to acquire cancer drug company Imago BioSciences for $1.35 billion to expand its portfolio to bone marrow diseases

primary article image

PermaLink

Raghav Mahobe

Reuters

Related: @jaybradner, Endpoints News, YouTube

FDA approves the first 'game-changing' treatment that delays onset of Type 1 diabetes. The drug, teplizumab, is developed New Jersey-based Provention Bio

primary article image

PermaLink

Adrianna Rodriguez

USA Today

Related: US FDA, BioPharma Dive

Elizabeth Holmes, the Founder & former CEO of blood testing startup Theranos, sentenced to 11 years & three months in prison for fraud

primary article image

PermaLink

Condé Nast

Vogue

Related: New York Times, CNN

Eisai & Biogen's drug lecanemab for Alzheimer's disease shown to slow disease progress by 27% compared with a placebo, in a 1795-patient landmark clinical trial

primary article image

PermaLink

Rebecca Robbins

New York Times

Related: Reuters, Investor's Business Daily, Biogen

High profile gene editing startup Prime Medicine files for IPO

primary article image

PermaLink

Ben Fidler

BioPharma Dive

Related: Endpoints News, Genetic Engineering & Biotechnology News, US Securities and Exchange Commission - US SEC

When the Fed's fight inflation and stock market is struggling, biotech may offer a line of hope

primary article image

PermaLink

Investor'S Business Daily

Investor's Business Daily


Catalent, one of the major pharma contract manufacturers, was cited by FDA for quality issues at its Covid-19 vaccine production site in Indiana

primary article image

PermaLink

Tyler Patchen

Endpoints News


BrainStorm to seek FDA approval for its amyotrophic lateral sclerosis drug NurOwn. FDA rejected NurOwn last year. The company re-analyzed its phase III data, made corrections, and re-submitted to the Agency

primary article image

PermaLink

Heather McKenzie

BioSpace


Monkeypox, whose transition once believed as self-limiting, forces researchers to re-learn how it spreads differently now, as cases ballooning rapidly around the globe (- Statnews)

primary article image

PermaLink

Megan Molteni

STAT

Related: Nature

Pfizer CEO tests positive on Covid, experiencing mild symptoms, is on Pfizer's Covid drug Paxlovid

primary article image

PermaLink

Reuters Staff

The Jerusalem Post | JPost.com

Related: @AlbertBourla

Monkeypox cases spreading in 20 countries of Europe, North America, and South America. The World Health Organization describes the epidemic as “containable”

primary article image

PermaLink

Maria Cheng

AP - The Associated Press

Related: CDC, STAT, Reuters

Pfizer and BioNTech's Covid vaccine shown a booster (third) shot in children of 5 to 11 years had 36X increase in Omicron neutralizing titers, and other increased immune responses. The companies to seek FDA authorization

primary article image

PermaLink

Julia Musto

Fox News

Related: pfizer

Latest News

Gilead Lung Cancer Study Update #Gilead #lungcancer #clinicaltrial GILD

23 Jan 2024 • 11:37 PM EST, YouTube


Is Gilead's 10% Crash — Resulting In A Failed Breakout — An Overreaction?

22 Jan 2024 • 4:08 PM EST, Investor'S Business Daily, Investor's Business Daily


Stock Price, Quote and News

22 Jan 2024 • 10:01 AM EST, CNBC


Gilead Provides Update on Phase 3 EVOKE-01 Study

22 Jan 2024 • 9:53 AM EST, gilead


Humana warns higher medical costs may hit 2024 forecast

18 Jan 2024 • 7:00 PM EST, CNBC


Healthcare Company Humana: A Quick Rant #healthcare #stockmarket $HUM

18 Jan 2024 • 2:40 PM EST, YouTube


Humana’s stock tumbles as Medicare Advantage growth disappoints

18 Jan 2024 • 12:02 PM EST, Eleanor Laise, MarketWatch


Review of Pharma Company AbbVie: Part 2

17 Jan 2024 • 10:19 PM EST, YouTube


Review of Pharma Company AbbVie Part 1

17 Jan 2024 • 10:11 PM EST, YouTube


Chinese Gene-Editing Scientist He Jiankui Sets Up Beijing Lab Following Prison Release

27 Nov 2022 • 11:58 PM EST, Staff Writer, Pandaily